Arkolith/Insider Trading/ONCY/Form 4

Kelly Jared

Chief Executive Officer, DirectorONCOLYTICS BIOTECH INC (ONCY) · full profile →Form 4 · filed Feb 13, 2026
Net Buying
Open-Market Buys
$29K
Open-Market Sells
$0
Net Open-Market Flow
$29K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 12, 2026Buy(P)30K$0.84$25K109K
Feb 11, 2026Buy(P)6K$0.84$5K80K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-006545) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML